Allied Market Research

2024

Clinical Trials Market

Clinical trials Market Size, Share, Competitive Landscape and Trend Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Indication (Autoimmune/Inflammation, Pain management, Cardiovascular, CNS condition, Oncology, Diabetes, Obesity, Others), by Service Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, Others) and by Sponsor (Pharmaceutical and Biopharmaceutical Companies, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Clinical trials Market Outlook – 2027       

Clinical trials Market            

There are two types of medical research which consists of the people. The two types of trials are called:

  1. Observational studies

  2. Clinical trials

  • In observational studiespeople are observed in a normal atmosphere. After the observation’s researchers collect the details, based on the characteristics of the group volunteers, and estimate any changes occurring over time.

  • In Clinical trials the research studies carried out are focused on the people who aim at the evaluation of surgical, medical, and any interventions in the behaviour. In the most basic and primary way which helps the researchers in figuring out the treatment, like the introduction of the novel diet, drug or medical device for the effectiveness and safety of the people. Clinical trials help in finding out the treatments the level of effectiveness or if it is less harmful than the current treatment.

  • Clinical trials also help in the early detection, occasionally even before the symptoms are observed. Clinical trials are divided into four phases for the treatment testing, and to find dosage appropriate for the treatment, and analyze if they are any side effects. Once the three phases have been passed and the researchers found the drugs and if they are safe and effective at the same time, an approval is passed from the FDA and monitors its effects further for the medicinal use.                                  

COVID-19 scenario analysis:                                             

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.

Owing to such factors, COVID 19 is expected to have a significant impact on the Clinical trials market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

There has been an increase in the frequencies of chronic diseases like cancer and diabetes along with the demand for clinical trials increasing in developing economies are the major factors propelling the clinical trials market. There has also been an increase in biologics, requirements for orphan as well as personalized medicines are boosting the clinical trials market. The demands for upgrades in the technologies are also creating a surge in the clinical trials market.

Evolution in the technology, clinical trials globalization, and Contract Research Organizations (CROs) demand for conducting the clinical trials are also boosting the growth.

On the other hand, the rеgulаtіоnѕ and policies are for running the сlіnісаltrіаlѕ on the population, сlіnісаltrіаlѕаrе very expensive and the cost shifts in every phase of the clinical trial which are the biggest challenges faced by the clinical trials market at this moment. Additionally, the аdорtіоn rate оf сlіnісаltrіаlѕ performed virtually which collects the data for the ѕаfеtу of the раrtісіраntѕ and the traveling is minimal in this case.

New product launches and acquisitions to flourish the market:

On March 12th, 2020, Eli Lilly and AbCellera joined hands for developing vaccines for COVID-19 by antibody therapies.

On March 27th, 2020, Novartis, GSK, MSD, and Bill & Melinda Gates Foundation are working on finding a cure for COVID-19.

On April 14th, 2020, Sanofi and GSK collaborated for finding out a cure for the COVID-19 vaccine.

On January 13th, 2020, Wuxi AppTec introduced adeno-associated virus which is a fully integrated vector suspension Platform.

Surge in usage in Contract Research Organizations applications:

Contract Research Organizations (CROs) are the biggest end-users are in the clinical trials market. These CROs have gone through different acquisitions and mergers to acquire new technology.

Key benefits of the report:

  • This study presents the analytical depiction of the global Clinical trials industry along with the current trends and future estimations to determine the imminent investment pockets.

  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Clinical trials market share.

  • The current market is quantitatively analyzed to highlight the global growth scenario.

  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.

  • The report provides a detailed global Clinical trials market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Clinical trials Market research report:

  • What are the leading market players active in the Clinical trials market?

  • What the current trends will influence the market in the next few years?

  • What are the driving factors, restraints, and opportunities in the market?

  • What are the projections for the future that would help in taking further strategic steps?

Clinical trials Market Report Highlights

Aspects Details
Clinical trials Market By Phase
By Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Clinical trials Market By Indication
By Indication
  • Autoimmune/Inflammation
  • Pain management
  • Cardiovascular
  • CNS condition
  • Oncology
  • Diabetes
  • Obesity
  • Others
Clinical trials Market By Service Type
By Service Type
  • Protocol Designing
  • Site Identification
  • Patient Recruitment
  • Laboratory Services
  • Bioanalytical Testing Services
  • Clinical Trial Data Management Services
  • Others
Clinical trials Market By Sponsor
By Sponsor
  • Pharmaceutical and Biopharmaceutical Companies
  • Others
Clinical trials Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Institutional Review Boards, Academic Research Institutes, Contract Research Organizations, Hospitals & Clinics, Technical Experts, Consulting Organizations, Software Companies, Regulatory Agencies, Data Management Organizations, Pharmaceutical Companies

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Clinical trials Market

Global Opportunity Analysis and Industry Forecast, 2023-2032